Skip to Content
Merck

RIP5 is a RIP-homologous inducer of cell death.

Biochemical and biophysical research communications (2004-06-05)
Jikun Zha, Qianhe Zhou, Liang-Guo Xu, Danying Chen, Lixia Li, Zhonghe Zhai, Hong-Bing Shu
ABSTRACT

Members of the RIP serine/threonine kinase family are involved in activation of NF-kappaB, JNK, and p38, and induction of apoptosis. Here we report the identification of a novel RIP-homologous protein designated as RIP5. The C-terminus of RIP5 contains a kinase domain, which is mostly homologous with the kinase domain of RIP. RIP5 also contains a large unconserved N-terminal domain. Overexpression of RIP5 induces cell death with characteristic apoptotic morphology. Overexpression of RIP5 also induces DNA fragmentation and this is blocked by the caspase inhibitor crmA. However, RIP5-induced apoptotic morphology is not blocked by crmA. These findings suggest that RIP5 may induce both caspase-dependent apoptosis and caspase-independent cell death.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
RIPK5, active, GST tagged human, PRECISIO® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution